Global Biotechnology - Market Summary, Competitive Analysis and Forecast to 2025
Summary
Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The global biotechnology market had total revenues of $529.1bn in 2020, representing a compound annual growth rate (CAGR) of 7.8% between 2016 and 2020.
- The Medical/Healthcare segment was the market's most lucrative in 2020, with total revenues of $302.6bn, equivalent to 57.2% of the market's overall value.
- In the wake of the COVID-19 pandemic, which has stalled the global economy and brought unprecedented levels of uncertainty in many sectors, the future of biotechnology is uncertain. However, in the mid to long-term the market should benefit from rising investment in medicines and government support, aiding growth.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the global
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalbiotechnology market
- Leading company profiles reveal details of key biotechnology market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Global biotechnology market with five year forecasts
Reasons to Buy
- What was the size of the Global biotechnology market by value in 2020?
- What will be the size of the Global biotechnology market in 2025?
- What factors are affecting the strength of competition in the Global biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up the global's biotechnology market?
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Are there any notable threats to leading players in this market?
7.5. Are there any other notable players in the market?
7.6. How might the COVID-19 pandemic affect the competitive landscape?
8 Company Profiles
8.1. Johnson & Johnson
8.2. F. Hoffmann-La Roche Ltd
8.3. Novartis AG
8.4. Bayer AG
8.5. Takeda Pharmaceutical Company Limited
8.6. BioNTech SE
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
List of Tables
Table 1: Global biotechnology industry value: $ billion, 2016-20
Table 2: Global biotechnology industry category segmentation: $ billion, 2020
Table 3: Global biotechnology industry geography segmentation: $ billion, 2020
Table 4: Global biotechnology industry value forecast: $ billion, 2020-25
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: F. Hoffmann-La Roche Ltd: key facts
Table 10: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 11: F. Hoffmann-La Roche Ltd: Key Employees
Table 12: Novartis AG: key facts
Table 13: Novartis AG: Annual Financial Ratios
Table 14: Novartis AG: Key Employees
Table 15: Novartis AG: Key Employees Continued
Table 16: Bayer AG: key facts
Table 17: Bayer AG: Annual Financial Ratios
Table 18: Bayer AG: Key Employees
Table 19: Bayer AG: Key Employees Continued
Table 20: Takeda Pharmaceutical Company Limited: key facts
Table 21: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 22: Takeda Pharmaceutical Company Limited: Annual Financial Ratios (Continued)
Table 23: Takeda Pharmaceutical Company Limited: Key Employees
Table 24: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 25: BioNTech SE: key facts
Table 26: BioNTech SE: Annual Financial Ratios
Table 27: BioNTech SE: Key Employees
Table 28: Global exchange rate, 2016-20
List of Figures
List of Figures
Figure 1: Global biotechnology industry value: $ billion, 2016-20
Figure 2: Global biotechnology industry category segmentation: % share, by value, 2020
Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: Global biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the global biotechnology industry, 2020
Figure 6: Drivers of buyer power in the global biotechnology industry, 2020
Figure 7: Drivers of supplier power in the global biotechnology industry, 2020
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2020
Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2020
Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2020
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Novartis AG
Bayer AG
Takeda Pharmaceutical Company Limited
BioNTech SE
听
听
*If Applicable.
